Dynamic Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Dynamic Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,049	Closed	-$1.42M	–	129
2018 Q2	$1.42M	Buy	+15,049	New	+$1.32M	2.26%	9
2018 Q1	–	Sell	-26,291	Closed	-$2.34M	–	103
2017 Q4	$2.34M	Sell	26,291 -8,990	-25%	-$782K	0.81%	32
2017 Q3	$3.28M	Buy	35,281 +21,626	+158%	+$1.91M	0.94%	25
2017 Q2	$1.24M	Sell	13,655 -5,731	-30%	-$521K	0.28%	80
2017 Q1	$1.7M	Sell	19,386 -6,122	-24%	-$545K	0.28%	104
2016 Q4	$2.11M	Sell	25,508 -69	-0.3%	-$5.93K	0.23%	146
2016 Q3	$2.37M	Buy	25,577 +9,627	+60%	+$907K	0.3%	107
2016 Q2	$1.24M	Buy	+15,950	New	+$1.36M	0.15%	234
2015 Q4	–	Sell	-17,542	Closed	-$1.85M	–	356
2015 Q3	$1.85M	Sell	17,542 -69,859	-80%	-$9.33M	0.51%	54
2015 Q2	$12M	Buy	+87,401	New	+$10.8M	3.04%	4
2014 Q2	–	Sell	-26,289	Closed	-$1.79M	–	401
2014 Q1	$1.79M	Buy	26,289 +17,346	+194%	+$1.28M	0.58%	25
2013 Q4	$629K	Buy	8,943 +3,043	+52%	+$207K	0.12%	279
2013 Q3	$426K	Sell	5,900 -2,059	-26%	-$137K	0.09%	315
2013 Q2	$444K	Buy	+7,959	New	+$496K	0.12%	229

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Capital Management's BMRN Position: Q3 2018 in Review

Dynamic Capital Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2018, closing a stake of 15,049 shares — an estimated $1.42M sold.

Dynamic Capital Management first reported a position in BMRN in Q2 2013 and held it in 14 quarters. The position peaked at $12M in Q2 2015. 460 funds tracked by Wall St. Rank hold BMRN as of Q3 2018.

Dynamic Capital Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Dynamic Capital Management sold 15,049 BioMarin Pharmaceuticals shares in Q3 2018, an estimated $1.42M.
Dynamic Capital Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Dynamic Capital Management's BioMarin Pharmaceuticals position peaked at $12M in Q2 2015.
460 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2018.

Based on Dynamic Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.